m6A-mediated lnc-OXAR promotes oxaliplatin resistance by enhancing Ku70 stability in non-alcoholic steatohepatitis-related hepatocellular carcinoma
Abstract Background The escalating prevalence of metabolic diseases has led to a rapid increase in non-alcoholic steatohepatitis (NASH)-related hepatocellular carcinoma (NASH-HCC). While oxaliplatin (OXA)-based hepatic arterial infusion chemotherapy (HAIC) has shown promise in advanced-stage HCC pat...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2024-07-01
|
| Schriftenreihe: | Journal of Experimental & Clinical Cancer Research |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1186/s13046-024-03134-4 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
